2025-04-25
Nature Medicine Review: AI Reconstructs the Paradigm of Drug Development
In the prolonged battle between humanity and disease, drug development remains the decisive battleground. Faced with the harsh reality of an average investment of $2.6 billion, a 15-year timeline, and a success rate below 10%, global scientists are turning to artificial intelligence (AI). This disruptive technology is quietly ushering drug development into a new era of "algorithm-driven" innovation. By 2025, the latest research in Nature journals reveals that generative AI models, exemplified by ChatGPT and Sora, are reshaping the entire drug development pipeline—from target discovery to clinical trials—accelerating "AI-driven drug discovery" from concept to clinical practice.
2025-04-18
Imagine if immune cells in the human body could transform into "smart missiles," relentlessly tracking and destroying cancer cells without harming healthy tissue—this would revolutionize cancer treatment. A groundbreaking announcement from the USC Viterbi School of Engineering reveals the arrival of "EchoBack CAR T cells", a new breed of "thinking" immune warriors propelling targeted cancer therapy into a 2.0 era!
2025-04-17
Gene Scissors 2.0 Unveiled! New Tech Enables "Precision Gene Transplantation"
Nature hailed the breakthrough: "STITCHR fills critical technological gaps and heralds a new era of precision medicine." As clinical trials advance, this molecular revolution—orchestrated by RNA and jumping genes—is set to redefine humanity’s foundational approach to combating disease.
2025-04-11
These advancements demonstrate the feasibility of gene-editing and cloning in resurrecting extinct species, attracting increased funding and scientific collaboration. This progress elevates genetic technology’s potential in biodiversity conservation, biopharmaceuticals, and beyond, heralding a new era of ecological restoration and innovation.
2025-04-11
On April 8 (Tuesday), Xijing Hospital of Air Force Medical University announced a major breakthrough in Asia’s first gene-edited pig kidney transplant for a patient with end-stage renal disease. The patient has maintained stable kidney function for 32 days post-surgery and met discharge standards. This achievement marks a milestone in China’s clinical research on xenotransplantation, offering new hope for patients with terminal kidney disease.
2025-02-07
Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements
With the rapid development of science and technology, humanity's exploration of life has never ceased. During the 2023-2024 period, we witnessed a series of exciting scientific achievements. These not only made significant progress in fields such as anti-aging, gene editing, organ regeneration, and immunotherapy but also pointed the way for future medical research.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
